Journal of Inherited Metabolic Disease 2002-05-01

3-Hydroxyglutarate excretion is increased in ketotic patients: implications for glutaryl-CoA dehydrogenase deficiency testing.

J Pitt, K Carpenter, B Wilcken, A Boneh

Index: J. Inherit. Metab. Dis. 25(2) , 83-8, (2002)

Full Text: HTML

Abstract

Three patients with ketosis had increased excretion of 3-hydroxyglutarate (21.8-37.9 micromol/mmol creatinine; controls 2.3 +/- 1.6), an indicator of glutaryl-CoA dehydrogenase deficiency (GDHD), which normalized when the patients were nonketotic. Clinical assessment of all three patients and enzyme studies in one patient were not consistent with GDHD. These findings were compared with those of other ketotic patients, who showed statistically significant increases in 3-hydroxyglutarate excretion (9.4 +/- 5.0 micromol/mmol creatinine; p < 0.01), and with those of a child with confirmed GDHD when she was both ketotic and nonketotic. Secondary increase in 3-hydroxyglutarate excretion during ketosis is a potential confounder in the diagnosis of GDHD.


Related Compounds

Related Articles:

Virtual and biomolecular screening converge on a selective agonist for GPR30.

2006-04-01

[Nat. Chem. Biol. 2 , 207-12, (2006)]

Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.

2009-12-10

[J. Med. Chem. 52 , 7488-502, (2009)]

The effect of steroids on the in vitro migration of washed human spermatozoa in modified Tyrode's solution or in fasting human blood serum.

1979-11-01

[Fertil. Steril. 32(5) , 566-70, (1979)]

More Articles...